IL1B and gout: Notably, the E127Q and E127S variants significantly reduced mRNA levels of the key pro-inflammatory cytokines IL-1β and IL-6-central players in the pathogenesis of diseases such as rheumatoid arthritis, gout, and other IL-1-driven conditions.